These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 10432997)

  • 21. History of HDR afterloading in brachytherapy.
    Vahrson H; Glaser FH
    Sonderb Strahlenther Onkol; 1988; 82():2-6. PubMed ID: 3134716
    [No Abstract]   [Full Text] [Related]  

  • 22. Salvage high-dose-rate (HDR) brachytherapy for recurrent head-and-neck cancer.
    Hepel JT; Syed AM; Puthawala A; Sharma A; Frankel P
    Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1444-50. PubMed ID: 16029806
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The radiation therapy of skin cancer (fractionation variants and methodology)].
    Vorob'ev IuI; Limarova IV; Pechurchik AI; Garbuzov MI; Sulaev LA
    Vopr Onkol; 1995; 41(2):90-1. PubMed ID: 7483454
    [No Abstract]   [Full Text] [Related]  

  • 24. Dermatological high-dose-rate brachytherapy for the treatment of basal and squamous cell carcinoma.
    Sedda AF; Rossi G; Cipriani C; Carrozzo AM; Donati P
    Clin Exp Dermatol; 2008 Nov; 33(6):745-9. PubMed ID: 18681873
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Image-guided cervix high-dose-rate brachytherapy treatment planning: does custom computed tomography planning for each insertion provide better conformal avoidance of organs at risk?
    Davidson MT; Yuen J; D'Souza DP; Batchelar DL
    Brachytherapy; 2008; 7(1):37-42. PubMed ID: 18299111
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Electron and high-dose-rate brachytherapy boost in the conservative treatment of stage I-II breast cancer first results of the randomized Budapest boost trial.
    Polgár C; Fodor J; Orosz Z; Major T; Takácsi-Nagy Z; Mangel LC; Sulyok Z; Somogyi A; Kásler M; Németh G
    Strahlenther Onkol; 2002 Nov; 178(11):615-23. PubMed ID: 12426672
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Experiences with a new high-dose-rate brachytherapy (HDR-BT) boost technique for T3b prostate cancer.
    Rades D; Schwarz R; Todorovic M; Thurmann H; Graefen M; Walz J; Schild SE; Dunst J; Alberti W
    Strahlenther Onkol; 2007 Jul; 183(7):398-402. PubMed ID: 17609874
    [TBL] [Abstract][Full Text] [Related]  

  • 28. We congratulate Kaspert's et al. for an extensive review of reirradiation in recurrent and second primary head and neck tumors.
    Chopra S; Agarwal JP
    Oral Oncol; 2005 Oct; 41(9):953-4. PubMed ID: 15935725
    [No Abstract]   [Full Text] [Related]  

  • 29. Feasibility of combined operation and perioperative intensity-modulated brachytherapy of advanced/recurrent malignancies involving the skull base.
    Strege RJ; Kovács G; Maune S; Holland D; Niehoff P; Eichmann T; Mehdorn HM
    Strahlenther Onkol; 2005 Feb; 181(2):97-107. PubMed ID: 15702298
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Radiotherapy problems by skin tumors in the facial folds].
    Mayer A; Zaránd P
    Hautarzt; 1981 Oct; 32(10):529-31. PubMed ID: 7298333
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of upper gum carcinoma with high-dose-rate customized-mold brachytherapy.
    Garrán C; Montesdeoca N; Martínez-Monge R
    Brachytherapy; 2008; 7(3):267-9. PubMed ID: 18635026
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In regard to Wahl et al. (Int J Radiat Oncol Biol Phys 2008;70:477-484).
    Hannoun-Levi JM; Raoust I
    Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1603-4; author reply 1604. PubMed ID: 18640511
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical quality assurance for 106Ru ophthalmic applicators.
    Kaulich TW; Zurheide J; Haug T; Nüsslin F; Bamberg M
    Radiother Oncol; 2005 Jul; 76(1):86-92. PubMed ID: 15972240
    [TBL] [Abstract][Full Text] [Related]  

  • 34. History and development of HDR afterloading in Japan.
    Hashimoto S; Ito H
    Sonderb Strahlenther Onkol; 1988; 82():10-5. PubMed ID: 3134702
    [No Abstract]   [Full Text] [Related]  

  • 35. [On the radiation therapy of the protuberant dermatofibrosarcoma (author's transl)].
    Schmidt W; Schwarzbach C; Kühne KH
    Radiobiol Radiother (Berl); 1980 Oct; 21(5):580-5. PubMed ID: 7208846
    [No Abstract]   [Full Text] [Related]  

  • 36. [Treatment of conjunctival epithelial tumors: brachytherapy with ruthenium-106].
    Buc D; Pilon F; Donnarieix D; Kemeny JL; Bacin F; Rigal D
    J Fr Ophtalmol; 2003 Nov; 26(9):929-39. PubMed ID: 14631277
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Brachytherapy for primary and recurrent nasopharyngeal carcinoma: treatment techniques and results.
    Maalej M; Ben Ammar CN; Kochbati L; Frikha H; Hentati D; Gargouri W; Besbes M
    Cancer Radiother; 2007 May; 11(3):117-21. PubMed ID: 17293150
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Positional variability of a tandem applicator system in HDR brachytherapy for primary treatment of cervix cancer. Analysis of the anatomic pelvic position and comparison of the applicator positions during five insertions.
    Wulf J; Popp K; Oppitz U; Baier K; Flentje M
    Strahlenther Onkol; 2004 Apr; 180(4):216-24. PubMed ID: 15057432
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The use of Valencia applicators at extended source surface distances for irregular surface contours.
    Byrne M; Arthur G
    Australas Phys Eng Sci Med; 2014 Mar; 37(1):115-20. PubMed ID: 24532418
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The use of the MammoSite balloon applicator in re-irradiation of the breast.
    Trombetta M; Julian T; Miften M; McWilliams W; Kim Y; Parda D
    Brachytherapy; 2008; 7(4):316-9. PubMed ID: 18786865
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.